STARD7 and colitis: We show that reconstitution of mitochondrial activity by AMP kinase (AMPK) activation in human intestinal cells led to improved barrier integrity and that treatment of Stard7+/– with an AMPK agonist demonstrated protection from the colitis phenotype in mice.